Research output per year
Research output per year
Personal profile
Side activities
Committees
- NVFK, Scientific advisory board (WAR) (from 2021 onwards)
- KNGF, working group 'kwaliteitsdocument SMA type 2 en 3' NVFK (from 2022 onwards)
- KNGF, working group 'ontwikkeling van een landelijk zorgnetwerk spierziekten Kennisinstituut FMS (from 2021 onwards)
Advisory boards, consultancy (Payments are always to UMC Utrecht)
- Scholar Rock, Physical Therapist Thought Leader Advisory Board SRK-015 Phase 2 Trial in SMA (from 2018 onwards)
- Biogen, advisor and trainer ESBBT ASCEND trial and DEVOTE trial (from 2021 onwards)
- Biogen, development SMA exercise app (from 2021 onwards)
- F. Hoffmann-La Roche Ltd, Expert Advisory Group, Benchmarking Care for Adults Living with SMA across Europe (from 2022 onwards
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Exploring functional strength changes during nusinersen treatment in symptomatic children with SMA types 2 and 3
van der Woude, D. R., Wadman, R. I., Asselman, F-L., Schoenmakers, M. A. G. C., Cuppen, I., van der Pol, W. L. & Bartels, B., Aug 2024, In: Neuromuscular Disorders. 41, p. 1-7 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Impact of contractures on daily functioning in adolescents with spinal muscular atrophy: a qualitative study
Oude Lansink, I. L. B., Gorter, J. W., van der Pol, W. L., Bartels, B. & Beelen, A., 2024, In: Disability and Rehabilitation. 46, 12, p. 2593-2599 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Monitoring Nusinersen Treatment Effects in Children with Spinal Muscular Atrophy with Quantitative Muscle MRI
Otto, L. A. M., Froeling, M., Van Eijk, R. P. A., Wadman, R. I., Cuppen, I., Van Der Woude, D. R., Bartels, B., Asselman, F. L., Hendrikse, J. & Van Der Pol, W. L., 2 Jan 2024, In: Journal of Neuromuscular Diseases. 11, 1, p. 91-101 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Downloads (Pure) -
254th ENMC international workshop. Formation of a European network to initiate a European data collection, along with development and sharing of treatment guidelines for adult SMA patients. Virtual meeting 28 – 30 January 2022
Jun 2023, In: Neuromuscular Disorders. 33, 6, p. 511-522 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Electrophysiological and Imaging Biomarkers to Evaluate Exercise Training in Patients with Neuromuscular Disease: A Systematic Review
Pomp, L., Jeneson, J. A. L., van der Pol, W. L. & Bartels, B., 1 Nov 2023, In: Journal of Clinical medicine. 12, 21, p. 1-15 6834.Research output: Contribution to journal › Review article › peer-review
Open AccessFile9 Downloads (Pure)
Activities
-
Stanford University’s 5th Annual Neuromuscular Conference: Spinal Muscular Atrophy & Duchenne Muscular Dystrophy Lessons Learned in Genetic Treatments
Bart Bartels (Invited speaker)
8 Dec 2023 → 9 Dec 2023Activity: Participating in or organising an event › Participation in conference › Academic
-
Physiotherapy Preceptorship training SMA
Bart Bartels (Chair)
22 Nov 2023 → 24 Nov 2023Activity: Participating in or organising an event › Participation in workshop, seminar, course › Academic
-
Physiotherapy Preceptorship training SMA Utrecht
Bart Bartels (Chair)
8 Feb 2023 → 10 Feb 2023Activity: Participating in or organising an event › Participation in workshop, seminar, course › Academic
-
SMA: The National Approach to SMA, Utrecht, The Netherlands
Bart Bartels (Speaker)
2 Sept 2022Activity: Talk or presentation › Invited talk › Academic
-
Prizes
-
Talma-Eijkman Award Best Master Thesis
Bartels, Bart (Recipient), 2013
Prize: Prize (including medals and awards)
-
WCF proefschriftprijs 2021
Bartels, Bart (Recipient), 6 Oct 2021
Prize: Prize (including medals and awards)
Press/Media
-
On the horizon: opportunities to tackle neuromuscular disease SMA
15/12/20
1 Media contribution
Press/Media: Expert Comment